Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Marlene Busko

    News

    Semaglutide 2.4 mg ‘likely to usher in a new era’ in obesity treatment

    Author:
    Marlene Busko
    Publish date: June 29, 2021

    Clinical experience with this drug will grow rapidly over the next few years, one expert predicts, and new combination drugs are near, so...

    • Read More

    News

    Time-restricted eating ‘promising, but more data are needed’

    Author:
    Marlene Busko
    Publish date: June 26, 2021

    “Time-restricted eating is promising because of its simple message and noted weight-loss benefit, yet more data are needed,” says an expert.

    • Read More

    News

    Bariatric surgery tied to 22% lower 5-year stroke risk

    Author:
    Marlene Busko

    This study contributes to knowledge that suggests that reduction in ischemic stroke risk is yet another benefit of bariatric surgery, says a study...

    • Read More

    News

    Bariatric surgery’s cardiovascular benefit extends to 7 years

    Author:
    Marlene Busko
    Publish date: June 16, 2021

    This 7-year retrospective cohort study and two slightly shorter earlier ones showed heart benefits from...

    • Read More

    News

    Eat two fruits a day, ward off diabetes?

    Author:
    Marlene Busko
    Publish date: June 14, 2021

    Results from an observational study “support encouragement of the consumption of whole fruits, but not fruit juice, to preserve insulin...

    • Read More

    News

    New obesity target? Dopamine circuit in brainstem affects satiety

    Author:
    Marlene Busko
    Publish date: June 7, 2021

    A newly identified dopaminergic neural circuit in the hindbrain plays a role in satiety, a mouse study found, which methylphenidate acts on.

    • Read More

    News

    FDA approves ‘game changer’ semaglutide for weight loss

    Author:
    Marlene Busko
    Publish date: June 4, 2021

    Based on the STEP clinical trial results, the FDA has approved a 2.4 mg/week subcutaneous dose of the GLP-1 receptor agonist semaglutide (Wegovy,...

    • Read More

    News

    A simple new definition for ‘metabolically healthy obesity’?

    Author:
    Marlene Busko
    Publish date: May 10, 2021

    ‘Our new definition may be important not only to stratify risk of mortality in people with obesity, but also in people with overweight and normal...

    • Read More

    News

    Being overweight ups risk of severe COVID-19 in hospital

    Author:
    Marlene Busko
    Publish date: April 29, 2021

    This research “adds to the known data on the associations between obesity and severe COVID-19 disease and extends these findings” to patients who...

    • Read More

    News

    Severe obesity persists, takes high cardiovascular toll

    Author:
    Marlene Busko
    Publish date: April 21, 2021

    “This research highlights the high cardiovascular toll exacted by continuing failure to tackle obesity, particularly among more socioeconomically...

    • Read More

    News

    Eating more fat may boost borderline low testosterone

    Author:
    Marlene Busko
    Publish date: April 19, 2021

    “If somebody has low testosterone, particularly borderline, they could try increasing their fat intake, maybe on a Mediterranean diet, and see if...

    • Read More

    News

    Bariatric surgery may cut cancer in obesity with liver disease

    Author:
    Marlene Busko
    Publish date: April 9, 2021

    Among working adults with severe obesity and fatty liver disease, rates of cancer were lower after bariatric surgery during a 10-month median...

    • Read More

    News

    ‘Major update’ of BP guidance for kidney disease; treat to 120 mm Hg

    Author:
    Marlene Busko
    Publish date: March 16, 2021

    “[Chapter one] of the guidelines is devoted to blood pressure measurement ... if [targeting] 120 [mm Hg systolic], the emphasis is on 120 measured...

    • Read More

    News

    Semaglutide for meaningful weight loss in obesity and diabetes?

    Author:
    Marlene Busko
    Publish date: March 9, 2021

    “This is by far the best result we had with any weight loss medicine in patients with diabetes,” says the senior author of the STEP 2 clinical...

    • Read More

    News

    Semaglutide for weight loss? A good first STEP, with caveats

    Author:
    Marlene Busko
    Publish date: February 12, 2021

    “On the face of it, the STEP 1 trial (like its name) is a good beginning,” said the editorialists. More patients in the semaglutide group had...

    • Read More

    Pages

    • « first
    • …
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery